New research from the Minneapolis Heart Institute Foundation has uncovered a way to help interventional cardiologists better predict which patients are at higher risk for death following TAVR, allowing both patient and surgeon to discuss a potentially different treatment plan.

Results from a new study indicate that the addition of mitral valve (MV) repair to coronary artery bypass grafting (CABG) did not result in significant benefit to the patient and was associated with increased risk of neurological events. Therefore, the routine addition of MV repair to CABG in patients with moderate ischemic mitral regurgitation (IMR) did not demonstrate a clinically meaningful advantage.

Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project, investigating the impact of lifestyle modification on ablation outcome in atrial fibrillation (ISOLATE). The research is financed by Texas Cardiac Arrhythmia Research Foundation. The PocketECG cardiac monitoring system will be used for collecting and analyzing the ECG data in the project

A new procedure to combat obesity was recently performed by physicians at Dayton Interventional Radiology.

To help hospitals reduce technology-related risks, ECRI Institute publishes an annual list of Top 10 Health Technology Hazards.

Results of a new study challenge the current consensus in cardiology that peak myocardial edema only occurs just after a myocardial infarction.

BioCardia Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s application to begin a Phase III clinical trial of its bone marrow-derived CardiAMP Therapy for heart failure.